Company intelligence / Profile preview

oncgnostics

Jena, Thuringia, Germanypmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

oncgnostics has commercialized GynTect®, a CE-marked molecular diagnostic test for early detection of cervical cancer using DNA methylation markers. The company reports strong clinical performance in identifying women at risk of developing cervical neoplasia. Additional pipeline programs are in validation stages targeting head & neck and ovarian cancers.

Therapeutic areas: Oncology
Modalities: Diagnostic test (in vitro diagnostic)Device (PCR-based molecular diagnostics)Biomarker-based assay (epigenetic biomarkers/DNA methylation)
Industry: Molecular Diagnostics

Drug pipeline

1 asset

GynTect

Commercial

Indications: Cervical cancer

Partnerships

Exclusive license with SINOPHARM subsidiary CJMT for GynTect commercialization in China.Partnership with MEDIREX group for distribution in Slovakia and Czech Republic.

Beyond the preview

Go deeper on oncgnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on oncgnostics.

Explore the full profile